Furthermore, we found that the way for miR-1323 to regulate migration of LUAD was by targeting Cbl-b and high Cbl-b expression predicted better survival in NSCLC and LUAD patients. The gene discussed is CBLB; the disease is non-small cell lung carcinoma.